Vanguard Group Inc Tempest Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 297,877 shares of TPST stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
297,877
Previous 176,193
69.06%
Holding current value
$2.2 Million
Previous $148,000
1829.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TPST
# of Institutions
25Shares Held
1.97MCall Options Held
42.8KPut Options Held
72.9K-
Black Rock Inc. New York, NY550KShares$4.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA433KShares$3.2 Million0.0% of portfolio
-
Ubs Group Ag324KShares$2.39 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA115KShares$845,4450.0% of portfolio
-
Northern Trust Corp Chicago, IL99.4KShares$733,5050.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $76.9M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...